{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:35:34Z","timestamp":1789569334098,"version":"build-2803163510"},"reference-count":61,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Faculty of Medicine, Chiang Mai University, and the Fundamental Fund 2024","award":["FF063\/2567"],"award-info":[{"award-number":["FF063\/2567"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Metastasis remains the leading cause of death among patients with non-small cell lung cancer (NSCLC), emphasizing the urgent need for safer and more effective therapeutic options. Mitogen-activated protein kinase (MAPK) pathways play a crucial role in regulating EMT, migration, and invasion in NSCLC. Targeting these molecular mechanisms has become a key strategy in inhibiting NSCLC metastasis. Loureirin A and Loureirin B, flavonoids derived from the Thai traditional herb Dracaena loureiri, have shown potential pharmacological effects; however, their roles in NSCLC metastasis remain unexplored. This study aimed to elucidate the mechanisms by which Loureirin A and Loureirin B suppress EMT, migration, and invasion in NSCLC cells via the MAPK signaling pathway. The sulforhodamine B (SRB) assay showed that Loureirin A and Loureirin B, at concentrations ranging from 0 to 140 \u03bcM, were non-toxic to both A549 and H1299 cells. Additionally, Loureirins A and B exhibited no cytotoxic effects on primary human dermal fibroblast cells and did not induce hemolysis in red blood cells (RBCs). The wound-healing and trans-well assays were used to evaluate the anti-migratory and anti-invasion properties of Loureirin A and Loureirin B in NSCLC cell lines. Gelatin zymography was employed to investigate the activity of MMP-2 (gelatinase A) and MMP-9 (gelatinase B), while Western blot analysis was used to examine the expression of EMT markers and invasive proteins, and the phosphorylation of MAPK signaling molecules. Our results demonstrate that both Loureirin A and Loureirin B significantly suppressed the migration and invasion of A549 and H1299 cells. These compounds suppressed the activity of matrix metalloproteinases MMP-2 and MMP-9 and downregulated the expression of key invasive proteins including uPA, uPAR, and MT1-MMP. Additionally, they effectively suppressed the expression of EMT markers such as N-cadherin, Vimentin, and Fibronectin. Mechanistically, Loureirin A and Loureirin B inhibited the MAPK signaling pathway by downregulating the phosphorylation of ERK, JNK, and p38 proteins. In conclusion, these findings demonstrate that Loureirin A and Loureirin B exhibit potent anti-invasive properties and no cytotoxic effect on NSCLC cell lines, suggesting their potential as promising candidates for anti-cancer drug development. Furthermore, they may pave the way for the exploration of combination therapies with other anti-cancer drugs for clinical translation.<\/jats:p>","DOI":"10.3390\/life15030396","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T09:04:49Z","timestamp":1740992689000},"page":"396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting MAPK Signaling: Loureirins A and B from Dracaena Loureiri Inhibit Epithelial\u2013Mesenchymal Transition and Invasion in Non-Small Cell Lung Cancer Cell Lines"],"prefix":"10.3390","volume":"15","author":[{"given":"Xiaomin","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-4497","authenticated-orcid":false,"given":"Punnida","family":"Arjsri","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-7215","authenticated-orcid":false,"given":"Kamonwan","family":"Srisawad","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-1188","authenticated-orcid":false,"given":"Sonthaya","family":"Umsumarng","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-2283","authenticated-orcid":false,"given":"Supachai","family":"Yodkeeree","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-8911","authenticated-orcid":false,"given":"Pornngarm","family":"Dejkriengkraikul","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"},{"name":"Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"Kratzer","year":"2024","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: Current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Li, Y., Yan, B., and He, S. (2023). Advances and challenges in the treatment of lung cancer. Biomed. Pharmacother., 169.","DOI":"10.1016\/j.biopha.2023.115891"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-023-02660-6","article-title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","volume":"30","author":"Deutsch","year":"2024","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","article-title":"Progression and metastasis of lung cancer","volume":"35","author":"Popper","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14336\/AD.2019.0414","article-title":"Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-Based Study","volume":"11","author":"Gu","year":"2020","journal-title":"Aging Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/cncr.24871","article-title":"Five-year lung cancer survival: Which advanced stage nonsmall cell lung cancer patients attain long-term survival?","volume":"116","author":"Wang","year":"2010","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, J., and Kwok, H.F. (2020). Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment. Cancers, 12.","DOI":"10.3390\/cancers12061587"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"103194","DOI":"10.1016\/j.critrevonc.2020.103194","article-title":"Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives","volume":"157","author":"Imyanitov","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/jcp.25797","article-title":"Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis","volume":"232","author":"Chen","year":"2017","journal-title":"J. Cell Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT Transition States during Tumor Progression and Metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0022034512467352","article-title":"Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma","volume":"92","author":"Scanlon","year":"2013","journal-title":"J. Dent. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/carcin\/bgx063","article-title":"Matrix metalloproteinases: Their functional role in lung cancer","volume":"38","author":"Merchant","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000175156","article-title":"The plasminogen activator system and cancer","volume":"36","author":"McMahon","year":"2008","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kciuk, M., Gieleci\u0144ska, A., Budzinska, A., Mojzych, M., and Kontek, R. (2022). Metastasis and MAPK Pathways. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073847"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.2174\/13816128113196660763","article-title":"Signaling intermediates (MAPK and PI3K) as therapeutic targets in NSCLC","volume":"20","author":"Ciuffreda","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12943-024-02136-2","article-title":"Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: From clinical evidence to drug discovery","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1871520619666191015103712","article-title":"Anticancer Potential of Dietary Natural Products: A Comprehensive Review","volume":"20","author":"Ahmad","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00432-023-05572-7","article-title":"Natural products targeting the MAPK-signaling pathway in cancer: Overview","volume":"150","author":"Shi","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.21873\/anticanres.11154","article-title":"Potential Anti-Metastasis Natural Compounds for Lung Cancer","volume":"36","author":"Chanvorachote","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.2174\/0929867324666170918123413","article-title":"Perspectives of Plant Natural Products in Inhibition of Cancer Invasion and Metastasis by Regulating Multiple Signaling Pathways","volume":"25","author":"Sarwar","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1142\/S0192415X21500634","article-title":"Dragon\u2019s Blood from Dracaena Worldwide: Species, Traditional Uses, Phytochemistry and Pharmacology","volume":"49","author":"Liu","year":"2021","journal-title":"Am. J. Chin. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1055\/s-2002-34403","article-title":"Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri","volume":"68","author":"Likhitwitayawuid","year":"2002","journal-title":"Planta Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2014.10.059","article-title":"Antiplatelet Activity of Loureirin A by Attenuating Akt Phosphorylation: In Vitro Studies","volume":"746","author":"Hao","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105953","DOI":"10.1016\/j.intimp.2019.105953","article-title":"Downregulating Akt\/NF-\u03baB Signaling and Its Antioxidant Activity with Loureirin A for Alleviating the Progression of Osteoarthritis: In Vitro and Vivo Studies","volume":"78","author":"Hu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13020-019-0282-5","article-title":"Effect of Loureirin B on Crohn\u2019s disease rat model induced by TNBS via IL-6\/STAT3\/NF-\u03baB signaling pathway","volume":"15","author":"Sun","year":"2020","journal-title":"Chin. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Fan, W., Qu, Y., Yuan, X., Shi, H., and Liu, G. (Phytother. Res., 2024). Loureirin B Accelerates Diabetic Wound Healing by Promoting TGF\u03b2\/Smad-Dependent Macrophage M2 Polarization: A Concerted Analytical Approach Through Single-Cell RNA Sequencing and Experimental Verification, Phytother. Res., ahead of print.","DOI":"10.1002\/ptr.8373"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000430385","article-title":"Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-\u03b21-ERK\/JNK Pathway","volume":"37","author":"He","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/exd.12665","article-title":"Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-\u03b2\/Smad pathway","volume":"24","author":"Bai","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2015.08.006","article-title":"Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells","volume":"89","author":"Allen","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.sajb.2020.01.001","article-title":"Photochemoprotective effects of Spirulina platensis extract against UVB irradiated human skin fibroblasts","volume":"130","author":"Mapoung","year":"2020","journal-title":"S. Afr. J. Bot."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rorteau, J., Chevalier, F.P., Bonnet, S., Barth\u00e9lemy, T., Lopez-Gaydon, A., Martin, L.S., Bechetoille, N., and Lamartine, J. (2022). Maintenance of Chronological Aging Features in Culture of Normal Human Dermal Fibroblasts from Old Donors. Cells, 11.","DOI":"10.3390\/cells11050858"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Arjsri, P., Srisawad, K., Mapoung, S., Semmarath, W., Thippraphan, P., Umsumarng, S., Yodkeeree, S., and Dejkriengkraikul, P. (2022). Hesperetin from root extract of Clerodendrum petasites S. Moore inhibits SARS-CoV-2 spike protein S1 subunit-induced NLRP3 inflammasome in A549 lung cells via modulation of the Akt\/MAPK\/AP-1 pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810346"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jphotobiol.2016.12.033","article-title":"Photochemoprotective effects against UVA and UVB irradiation and photosafety assessment of Litchi chinensis leaves extract","volume":"167","author":"Thiesen","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Orellana, E.A., and Kasinski, A.L. (2016). Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. Bio Protoc., 6.","DOI":"10.21769\/BioProtoc.1984"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/7651_2019_259","article-title":"Scratch Wound Healing Assay","volume":"2109","author":"Martinotti","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Suarez-Arnedo, A., Torres Figueroa, F., Clavijo, C., Arbel\u00e1ez, P., Cruz, J.C., and Mu\u00f1oz-Camargo, C. (2020). An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE, 15.","DOI":"10.1101\/2020.04.20.050831"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.sajb.2021.02.005","article-title":"Spirogyra neglecta (Hassall) K\u00fctzing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway","volume":"139","author":"Arjsri","year":"2021","journal-title":"S. Afr. J. Bot."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review","volume":"322","author":"Arbour","year":"2019","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.6004\/jnccn.2018.0046","article-title":"Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer","volume":"16","author":"Reckamp","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Xie, S., Wu, Z., Qi, Y., Wu, B., and Zhu, X. (2021). The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges. Biomed. Pharmacother., 138.","DOI":"10.1016\/j.biopha.2021.111450"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/1386207325666220701121537","article-title":"Natural Flavonoids in the Prevention and Treatment of Lung Cancer: A Pharmacological Aspect","volume":"26","author":"Nath","year":"2023","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"153938","DOI":"10.1016\/j.phymed.2022.153938","article-title":"A comprehensive and current review on the role of flavonoids in lung cancer-Experimental and theoretical approaches","volume":"98","author":"Berk","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"112138","DOI":"10.1016\/j.jep.2019.112138","article-title":"Phenolic constituents, pharmacological activities, quality control, and metabolism of Dracaena species: A review","volume":"244","author":"Sun","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.3390\/molecules190710650","article-title":"A systematic review of the botanical, phytochemical and pharmacological profile of Dracaena cochinchinensis, a plant source of the ethnomedicine \u201cdragon\u2019s blood\u201d","volume":"19","author":"Fan","year":"2014","journal-title":"Molecules"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Huang, X., Arjsri, P., Srisawad, K., Yodkeeree, S., and Dejkriengkraikul, P. (2024). Exploring the Anticancer Potential of Traditional Thai Medicinal Plants: A Focus on Dracaena loureiri and Its Effects on Non-Small-Cell Lung Cancer. Plants, 13.","DOI":"10.3390\/plants13020290"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000512218","article-title":"Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target","volume":"211","author":"Jonckheere","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/fsn3.1495","article-title":"Dietary flavonoid myricetin inhibits invasion and migration of radioresistant lung cancer cells (A549-IR) by suppressing MMP-2 and MMP-9 expressions through inhibition of the FAK-ERK signaling pathway","volume":"8","author":"Kang","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7150\/ijms.50080","article-title":"Salinomycin suppresses TGF-\u03b21-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK\/SIRT1 pathway in non-small cell lung cancer","volume":"18","author":"Hwang","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4155\/fmc-2018-0468","article-title":"MAPK pathway: A potential target for the treatment of non-small-cell lung carcinoma","volume":"11","author":"Pradhan","year":"2019","journal-title":"Future Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.7150\/jca.18161","article-title":"Rac3 Regulates Cell Invasion, Migration and EMT in Lung Adenocarcinoma Through p38 MAPK Pathway","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Li, X., Cao, X., Zhao, H., Guo, M., Fang, X., Li, K., Qin, L., He, Y., and Liu, X. (2021). Hypoxia Activates Notch4 via ERK\/JNK\/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.780121"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1023781114568","article-title":"Role of MAP kinase in tumor progression and invasion","volume":"22","author":"Reddy","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biopha.2018.04.136","article-title":"Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK\/ERK signaling pathway","volume":"104","author":"Sun","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1248\/bpb.b23-00415","article-title":"Loureirin A Promotes Cell Differentiation and Suppresses Migration and Invasion of Melanoma Cells via WNT and AKT\/mTOR Signaling Pathways","volume":"47","author":"Xia","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.1007\/s12010-024-04975-7","article-title":"Loureirin B inhibits Cervical Cancer Development by Blocking PI3K\/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation","volume":"196","author":"Hong","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., and Taniguchi, K. (2021). Inflammation-Induced Tumorigenesis and Metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115421"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zappavigna, S., Cossu, A.M., Grimaldi, A., Bocchetti, M., Ferraro, G.A., Nicoletti, G.F., Filosa, R., and Caraglia, M. (2020). Anti-Inflammatory Drugs as Anticancer Agents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072605"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/3\/396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:46:17Z","timestamp":1760028377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/3\/396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["life15030396"],"URL":"https:\/\/doi.org\/10.3390\/life15030396","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}